• Flotek lifted 2026 guidance again, projecting total revenue of $360 million-$370 million.
• Adjusted EBITDA forecast raised to $50 million-$54 million.
• Prior 2026 outlook set Aug. 4 at revenue of $340 million-$350 million, Adjusted EBITDA of $47 million-$51 million.
• Midpoint implies 54% revenue growth, 58% Adjusted EBITDA growth versus 2025 reported results.
• International chemistry revenue was $10.6 million in Q2; second-half international chemistry sales expected to exceed $40 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flotek Industries Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DA43270) on September 09, 2026, and is solely responsible for the information contained therein.